Inhibikase Therapeutics (IKT) closed at $1.55 on November 10, 2026, down 7.7% from the previous close, on volume of 477,528 shares (30-day average 614,142).
Data as of November 10, 2026.
Analysts Offer Insights on NA Companies: Lucid Group (LCID) and Inhibikase Therapeutics (IKT)
TipRanks (Wed, 11-Nov 8:30 AM ET)
Inhibikase Therapeutics GAAP EPS of -$0.10 beats by $0.01
Seeking Alpha News (Tue, 10-Nov 5:03 PM ET)
Globe Newswire (Tue, 10-Nov 4:01 PM ET)
Globe Newswire (Tue, 27-Oct 8:00 AM ET)
Inhibikase Therapeutics Appoints Scott Wasserman to Board of Directors
Globe Newswire (Tue, 20-Oct 4:01 PM ET)
Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire (Fri, 2-Oct 4:01 PM ET)
Globe Newswire (Tue, 11-Aug 4:01 PM ET)
Market Chameleon (Tue, 14-Jul 7:08 AM ET)
Inhibikase Therapeutics Inc a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases, namely, Pulmonary Arterial Hypertension (PAH), in which aberrant signaling through type III receptor tyrosine kinases, including platelet derived growth factor receptors and a stem cell factor receptor, known as c-Kit, has been implicated. Its product candidate is IKT-001, a prodrug of imatinib mesylate (imatinib), for PAH which is an orphan indication. The company has developed its own portfolio of protein kinase inhibitors to treat bacterial and viral infections, including viral infections in the brain. It has one reporting segment, which is the business of developing protein kinase inhibitor therapeutics.
Inhibikase Therapeutics trades on the NASDAQ stock market under the symbol IKT.
As of November 11, 2026, IKT stock price climbed to $1.60 with 75,333 million shares trading.
IKT has a beta of 1.31, meaning it tends to be more sensitive to market movements. IKT has a correlation of 0.08 to the broad based SPY ETF.
IKT has a market cap of $223.26 million. This is considered a Small Cap stock.
In the last 3 years, IKT traded as high as $4.20 and as low as $.80.
The top ETF exchange traded funds that IKT belongs to (by Net Assets): VTI, IWM, VXF, IWN, VTWO.
IKT has underperformed the market in the last year with a return of +0.6%, while the SPY ETF gained +12.5%. In the last 3 month period, IKT fell short of the market, returning -35.0%, while SPY returned -1.5%. However, in the most recent 2 weeks IKT has outperformed the stock market by returning +1.9%, while SPY returned -1.3%.
IKT support price is $1.47 and resistance is $1.63 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IKT shares will trade within this expected range on the day.
